Company Name Voyager Therapeutics
Mailing Address 75 Sidney St. Cambridge, MA 02139 USA
Company Description Voyager Therapeutics is developing life-changing gene therapies for fatal and debilitating diseases of the central nervous system. Our founders include scientific and clinical leaders in the fields of adeno-associated virus (AAV) gene therapy, expressed RNA interference and neuroscience.
Proceeds Purposes Proceeds from the financing will be used to advance the company’s product pipeline, which includes five clinical and preclinical programs, as well as its industry-leading adeno-associated virus (AAV) product engine.